L Pasarell

1.5k total citations
23 papers, 1.2k citations indexed

About

L Pasarell is a scholar working on Infectious Diseases, Cell Biology and Epidemiology. According to data from OpenAlex, L Pasarell has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Cell Biology and 11 papers in Epidemiology. Recurrent topics in L Pasarell's work include Antifungal resistance and susceptibility (16 papers), Plant Pathogens and Fungal Diseases (12 papers) and Fungal Infections and Studies (7 papers). L Pasarell is often cited by papers focused on Antifungal resistance and susceptibility (16 papers), Plant Pathogens and Fungal Diseases (12 papers) and Fungal Infections and Studies (7 papers). L Pasarell collaborates with scholars based in United States and Belgium. L Pasarell's co-authors include Michael R. McGinnis, Chester R. Cooper, Michael G. Rinaldi, Annette W. Fothergill, Deanna A. Sutton, David W. Warnock, Renkai Li, Meral A. Cıblak, Michael A. Pfaller and Mohamad El‐Zaatari and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

L Pasarell

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Pasarell United States 18 818 777 317 250 134 23 1.2k
Manuel Cuenca‐Estrella Spain 21 1.2k 1.4× 1.0k 1.3× 457 1.4× 257 1.0× 173 1.3× 35 1.4k
Ilse Curfs-Breuker Netherlands 17 783 1.0× 649 0.8× 373 1.2× 198 0.8× 176 1.3× 24 1.0k
A W Fothergill United States 13 654 0.8× 505 0.6× 187 0.6× 105 0.4× 113 0.8× 16 885
G. S. Shankland United Kingdom 18 494 0.6× 540 0.7× 237 0.7× 117 0.5× 94 0.7× 39 884
Araceli Monzón Spain 19 1.3k 1.6× 1.1k 1.4× 467 1.5× 307 1.2× 210 1.6× 28 1.6k
R. Kappe Germany 16 603 0.7× 593 0.8× 284 0.9× 109 0.4× 125 0.9× 56 912
Leticia Bernal‐Martínez Spain 21 1.1k 1.3× 886 1.1× 293 0.9× 118 0.5× 117 0.9× 29 1.3k
Awatar S. Sekhon Canada 17 344 0.4× 472 0.6× 253 0.8× 139 0.6× 143 1.1× 56 734
Dora I. McCarthy United States 18 1.1k 1.4× 873 1.1× 519 1.6× 164 0.7× 387 2.9× 21 1.6k
Florence Persat France 20 796 1.0× 648 0.8× 106 0.3× 149 0.6× 102 0.8× 64 1.3k

Countries citing papers authored by L Pasarell

Since Specialization
Citations

This map shows the geographic impact of L Pasarell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Pasarell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Pasarell more than expected).

Fields of papers citing papers by L Pasarell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Pasarell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Pasarell. The network helps show where L Pasarell may publish in the future.

Co-authorship network of co-authors of L Pasarell

This figure shows the co-authorship network connecting the top 25 collaborators of L Pasarell. A scholar is included among the top collaborators of L Pasarell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Pasarell. L Pasarell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGinnis, Michael R. & L Pasarell. (2008). In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Medical Mycology. 36(4). 243–246. 5 indexed citations
2.
McGinnis, Michael R., et al.. (2001). Sporothrix schenckiisensitivity to voriconazole, itraconazole and amphotericin B. Medical Mycology. 39(4). 369–371. 47 indexed citations
3.
Li, Renkai, et al.. (2000). In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against Blastomyces dermatitidis , Coccidioides immitis , and Histoplasma capsulatum. Antimicrobial Agents and Chemotherapy. 44(6). 1734–1736. 147 indexed citations
4.
McGinnis, Michael R. & L Pasarell. (1998). In vitroevaluation of terbinafine and itraconazole against dematiaceous fungi. Medical Mycology. 36(4). 243–246. 48 indexed citations
5.
McGinnis, Michael R. & L Pasarell. (1998). In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Medical Mycology. 36(4). 243–246. 3 indexed citations
6.
McGinnis, Michael R., L Pasarell, Deanna A. Sutton, et al.. (1998). In vitro activity of voriconazole against selected fungi. Medical Mycology. 36(4). 239–242. 73 indexed citations
7.
McGinnis, Michael R. & L Pasarell. (1998). In Vitro Testing of Susceptibilities of Filamentous Ascomycetes to Voriconazole, Itraconazole, and Amphotericin B, with Consideration of Phylogenetic Implications. Journal of Clinical Microbiology. 36(8). 2353–2355. 104 indexed citations
8.
McGinnis, Michael R., L Pasarell, Deanna A. Sutton, et al.. (1998). In vitroactivity of voriconazole against selected fungi. Medical Mycology. 36(4). 239–242. 45 indexed citations
9.
Hajjeh, Rana, Sharon M. McDonnell, Susan E. Reef, et al.. (1997). Outbreak of Sporotrichosis among Tree Nursery Workers. The Journal of Infectious Diseases. 176(2). 499–504. 53 indexed citations
10.
McGinnis, Michael R., L Pasarell, Deanna A. Sutton, et al.. (1997). In vitro evaluation of voriconazole against some clinically important fungi. Antimicrobial Agents and Chemotherapy. 41(8). 1832–1834. 111 indexed citations
11.
Espinel-Ingroff, Ana, Marilyn S. Bartlett, Raleigh A. Bowden, et al.. (1997). Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. Journal of Clinical Microbiology. 35(1). 139–143. 201 indexed citations
12.
Shattuck, Karen E., et al.. (1996). Colonization and infection associated with Malassezia and Candida species in a neonatal unit. Journal of Hospital Infection. 34(2). 123–129. 24 indexed citations
13.
Pasarell, L, et al.. (1996). Recurrent Allergic Fungal Sinusitis Sequentially Caused byExserohilumandBipolaris. Annals of Saudi Medicine. 16(5). 564–567. 1 indexed citations
14.
Pfaller, Michael A., M. Lancaster, Ana Espinel‐Ingroff, et al.. (1994). Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology. 32(7). 1625–1628. 56 indexed citations
15.
Pasarell, L, et al.. (1993). A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy. Journal of Clinical Microbiology. 31(7). 1804–1810. 32 indexed citations
16.
Pasarell, L & Michael R. McGinnis. (1992). Viability of fungal cultures maintained at -70 degrees C. Journal of Clinical Microbiology. 30(4). 1000–1004. 43 indexed citations
17.
Sughayer, Maher A., et al.. (1991). Human Infection Caused by Exophiala pisciphila: Case Report and Review. Clinical Infectious Diseases. 13(3). 379–382. 31 indexed citations
18.
Pasarell, L, Michael R. McGinnis, & P G Standard. (1990). Differentiation of medically important isolates of Bipolaris and Exserohilum with exoantigens. Journal of Clinical Microbiology. 28(7). 1655–1657. 9 indexed citations
19.
Haque, Abida K., et al.. (1990). Disseminated Conidiobolus infection with endocarditis in a cocaine abuser.. PubMed. 114(12). 1276–8. 29 indexed citations
20.
El‐Zaatari, Mohamad, et al.. (1990). Evaluation of the updated Vitek yeast identification data base. Journal of Clinical Microbiology. 28(9). 1938–1941. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026